Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-12

Clinical Trial Update: Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® [Phase 4]

View source ↗

Summary

Phase 4 trial comparing safety and efficacy of Combigan and Lumigan versus Lumigan alone in glaucoma or ocular hypertension; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combigan (brimonidine tartrate and timolol maleate)
  • Lumigan (bimatoprost)
  • Xalatan (latanoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-01-12